How AI may hold the key to faster rare disease diagnosis
Leveraging artificial intelligence can shave years off the difficult process of diagnosing a rare disease. By safely sharing patient data, more will benefit globally.
Yann Le Cam, Gregory Moore, and Wolfram Nothaft
Yann Le Cam is Chief Executive Officer of EURORDIS-Rare Diseases Europe, a non-profit alliance of 956 rare disease patient organizations from 73 countries working to improve the lives of the 30 million people living with a rare disease in Europe.
Gregory Moore, MD, PhD, is an engineer, neuroradiologist, and the Corporate Vice President of Microsoft Health.
Wolfram Nothaft, MD, is a physician and the Chief Medical Officer at Takeda. Le Cam, Moore and Nothaft are co-chairs of the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease, which supports the efforts of Foundation 29.